HP
Hemmo Pharmaceuticals Pvt Ltd (Piramal Pharma Solutions)
CDMO · Navi Mumbai, India
GMP
Overview
Hemmo Pharmaceuticals is a peptide API maker that Piramal Pharma agreed to acquire in full in 2021, and it now operates within Piramal Pharma Solutions' peptide business. The Turbhe, Navi Mumbai GMP site makes peptides by solution- and solid-phase synthesis at multigram to kilogram scale. Hemmo's oxytocin API was the first to be prequalified by WHO (2019), and Hemmo holds an active US Type II DMF for oxytocin.
Capabilities
- Oxytocin API
- Solid- and solution-phase peptide synthesis
- Generic peptide APIs
- Custom peptide development
Quality signals
| GMP evidence | Yes |
|---|---|
| Certificates of analysis | Not found |
| Third-party testing | Not found |
| ISO certification | Not found |
| Makes own product | Yes, in-house production |
Sources
- piramalpharmasolutions.com/specialized-offerings/peptides-api
- piramal.com/wp-content/uploads/2021/03/Press-Release-Piramal-Pharma-Ltd.-To-Acquire-100-St
- extranet.who.int/prequal/news/first-oxytocin-active-pharmaceutical-ingredient-api-prequali
- fda.gov/drugs/drug-master-files-dmfs/list-drug-master-files-dmfs